ADHD Burden in Asia Peaks in Boys Aged 10 to 14, Landmark 34-Country Analysis Finds

Attention-deficit hyperactivity disorder has quietly become one of the most consequential childhood health challenges across Asia, and for the first time researchers have mapped its full footprint across 34 countries over more than three decades. Drawing on the Global Burden of Disease Study 2023, a team led by investigators at Kyung Hee University College of Medicine in Seoul quantified the disability associated with ADHD in every Asian nation from 1990 through 2023, revealing where the burden concentrates, who is most affected, and how the COVID-19 pandemic reshaped the landscape of this often-misunderstood condition.

The study defined ADHD using the standard diagnostic threshold of six or more symptoms of inattention or hyperactivity and impulsivity persisting for at least six months. Rather than counting diagnoses, which vary enormously with health system capacity and cultural attitudes, the researchers measured the burden in years lived with disability, or YLDs, a metric that captures the healthy time people lose to a condition. Age-standardized YLD rates were calculated with 95 percent uncertainty intervals and stratified by age, sex, region, and country, allowing the team to compare East Asia, Southeast Asia, South Asia, Central Asia, and the high-income Asia Pacific region on equal footing.

The headline finding is strikingly consistent: across every Asian region, the burden of ADHD peaks in early adolescence. Age-specific YLD rates climbed steadily through childhood and reached their maximum among children aged 10 to 14 years, hitting 213.03 per 100,000 population in East Asia, before declining progressively through later adolescence and adulthood. This developmental fingerprint matters because it pinpoints a narrow window when affected children experience the greatest functional impairment, precisely the years when academic demands intensify, peer relationships become more complex, and untreated symptoms can cascade into school failure, injury, and secondary mental health problems.

Sex differences proved equally robust. Males carried consistently higher YLD rates than females in every region and every age group examined, a pattern that echoes global epidemiology but carries particular weight in Asian settings where diagnostic services are often calibrated around hyperactive, disruptive presentations that are more common in boys. Researchers have long argued that girls with ADHD are systematically under-recognized because their symptoms tend toward inattention rather than outward hyperactivity, and the new Asian data underscore how that recognition gap translates into measurable differences in population-level disability.

Geographically, East Asia emerged as the region with both the largest increase in burden over the 34-year study period and the highest age-standardized YLD rate in 2023, at 82.20 per 100,000 population, with an uncertainty interval spanning 46.77 to 122.88. Yet the broader temporal picture is one of relative stability: age-standardized rates changed only modestly across Asia between 1990 and 2023, suggesting that the underlying prevalence of the disorder has not dramatically shifted even as awareness, diagnostic practice, and service provision have evolved unevenly across the continent.

One of the most consequential findings concerns the pandemic era. When the researchers compared pre- and post-pandemic periods, they found that the ADHD burden increased in most Asian countries during COVID-19, with particularly pronounced rises in the high-income Asia Pacific region. The result aligns with a growing body of evidence from individual countries, including studies documenting rising ADHD incidence in Korea and growing diagnostic volumes in Japan, and it is biologically and socially plausible: prolonged school closures, disrupted routines, reduced physical activity, and a massive shift toward screen-based learning all plausibly exacerbated attention difficulties in vulnerable children, while heightened parental observation at home may have accelerated recognition of pre-existing symptoms.

The analysis also uncovered a socioeconomic gradient that challenges assumptions about mental health and development. ADHD burden was positively correlated with the Socio-demographic Index, a composite measure of income, education, and fertility, meaning that wealthier, more developed Asian countries and regions tended to report higher disability rates. The authors and commentators interpret this pattern with caution: higher measured burden in developed settings likely reflects better case detection, greater diagnostic capacity, and reduced stigma rather than a genuinely higher underlying prevalence. In lower-income countries, the true toll of ADHD may be substantially underestimated because children are never assessed, a possibility with sobering implications for unmet need across South and Central Asia.

Why does this matter beyond the clinic? ADHD is not a transient childhood quirk that fades with age. It imposes lifelong economic and functional costs, affecting educational attainment, employment, relationships, and physical health, and prior economic analyses in the United States have estimated societal burdens running into tens of billions of dollars annually for children and adults alike. In Asia, where the study notes that comprehensive assessments have been limited until now, the absence of reliable regional data has hampered health planning, insurance coverage decisions, and the design of school-based interventions. By providing country-level estimates with quantified uncertainty, the new analysis gives ministries of health and education a common evidence base for the first time.

The authors are explicit about the practical implications. Their findings define males and children aged 10 to 14 years as priority groups for early detection and intervention across Asia. That framing carries weight because effective treatments exist: umbrella reviews and meta-analyses support both pharmacological and psychosocial interventions, including parent training programs and family-school collaboration models tested in randomized trials, and early intervention is consistently associated with better academic and social outcomes. Screening programs aimed at the peak-burden age window, coupled with clinician training to recognize inattentive presentations in girls, could meaningfully reduce the disability the study documents.

The study is not without limitations inherent to its design. The Global Burden of Disease framework relies on modeled estimates that synthesize surveillance data, published literature, and statistical adjustments, and uncertainty intervals, particularly in regions with sparse data, remain wide. Cultural differences in symptom thresholds, documented in comparative research between Hong Kong and the United Kingdom, can influence how parents and teachers rate the same child’s behavior, and the GBD methodology attempts to correct for such variation but cannot eliminate it. Nevertheless, the consistency of the age and sex patterns across all 34 countries lends credibility to the central conclusions, and the open availability of the underlying GBD data means other researchers can interrogate and extend the findings.

As Asia’s health systems grapple with the long shadow of the pandemic on child development, this analysis arrives at a pivotal moment. It confirms that ADHD is a substantial and persistent source of childhood disability across the continent, concentrated in a recognizable demographic, sensitive to social disruption, and most visible where societies are best equipped to look. The challenge now, the researchers argue, is to translate that visibility into action, ensuring that the boys and girls entering the peak-burden years of early adolescence in the coming decade are identified early and supported effectively, regardless of where in Asia they happen to be born.

Subject of Research: Regional and national burden of attention-deficit hyperactivity disorder across Asia from 1990 to 2023

Article Title: Regional and national burden of attention-deficit hyperactivity disorder in Asia, 1990–2023: a Global Burden of Disease Study 2023

Article References: Choi, Y., Kim, K., Yoo, H., Kim, D. Y., Kang, J., Kim, H., Oh, J., Woo, H. G., López-Gil, J. F., Nehs, C. J., Hwang, H. S., Park, J., & Yon, D. K. (2026). Regional and national burden of attention-deficit hyperactivity disorder in Asia, 1990–2023: a Global Burden of Disease Study 2023. World Journal of Pediatrics. https://doi.org/10.1007/s12519-026-01091-w

Image Credits: AI Generated

DOI: 10.1007/s12519-026-01091-w

Keywords: ADHD, Asia, Global Burden of Disease Study 2023, years lived with disability, children and adolescents, East Asia, COVID-19 pandemic, Socio-demographic Index, mental health, pediatrics, sex differences, early intervention